Tamoxifen in the treatment of recurrent ovarian carcinoma.
about
Hormone Receptors in Serous Ovarian Carcinoma: Prognosis, Pathogenesis, and Treatment ConsiderationsUse of aromatase inhibitors in practice of gynecologyGPR30 predicts poor survival for ovarian cancerEstrogen biosynthesis and action in ovarian cancer.Hormonal therapy in epithelial ovarian cancer.Recurrent epithelial ovarian cancer and hormone therapy.Active Estrogen Receptor-alpha Signaling in Ovarian Cancer Models and Clinical Specimens.Endocrine therapy in epithelial ovarian cancer.Differential expression of estrogen receptor subtypes and variants in ovarian cancer: effects on cell invasion, proliferation and prognosis.Estrogen receptor gene amplification occurs rarely in ovarian cancer.Tamoxifen and estradiol interact with the flavin mononucleotide site of complex I leading to mitochondrial failure.Evaluation of a hormone receptor-positive ovarian carcinoma subtype with a favourable prognosis by determination of progesterone receptor and oestrogen receptor 1 mRNA expression in formalin-fixed paraffin-embedded tissue.
P2860
Q26751021-81C403EE-6C4B-4F72-8FE1-8480B8984418Q27001218-3FD931FB-5B73-4D3C-9471-1D04C9F1241EQ34066297-FC9695BC-4BE6-402D-90D8-8E954546B9D3Q34496401-6EBF0955-4A3D-49A4-9CEB-D9CDC59285A6Q36352073-9E4CBE49-E880-464C-9AD6-EAA2C3C355F3Q37354691-646B7F71-1567-4BE6-A917-D72E3857B999Q39028384-8E7354D2-CCC1-4249-B53E-DDEB4373AFF6Q39038223-FBC6262E-0EBF-460F-88A6-822E175CAD9BQ41585965-7AF8F890-E16A-4393-B123-4065112C5D53Q44039602-0A9F8B06-EF54-4AB3-A013-3066306F5923Q46892776-807525DC-FC99-4E9F-B50A-09EB3A0DC4F3Q54338848-D26F9F0F-E19B-4B4A-A677-FD00413D2892
P2860
Tamoxifen in the treatment of recurrent ovarian carcinoma.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Tamoxifen in the treatment of recurrent ovarian carcinoma.
@ast
Tamoxifen in the treatment of recurrent ovarian carcinoma.
@en
Tamoxifen in the treatment of recurrent ovarian carcinoma.
@nl
type
label
Tamoxifen in the treatment of recurrent ovarian carcinoma.
@ast
Tamoxifen in the treatment of recurrent ovarian carcinoma.
@en
Tamoxifen in the treatment of recurrent ovarian carcinoma.
@nl
prefLabel
Tamoxifen in the treatment of recurrent ovarian carcinoma.
@ast
Tamoxifen in the treatment of recurrent ovarian carcinoma.
@en
Tamoxifen in the treatment of recurrent ovarian carcinoma.
@nl
P1476
Tamoxifen in the treatment of recurrent ovarian carcinoma.
@en
P304
P356
10.1016/S0959-8049(00)00228-8
P478
36 Suppl 4
P577
2000-09-01T00:00:00Z